Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GW.4NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
GW.4NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
GW.4NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
GW.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
GW.4NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
GW.4NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
GW.4NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-18100Germany
GW.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GW.4NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
GW.4NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-893.215Hong Kong
GW.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GW.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GW.4ORF1abNIID WH-1 F501R913TTCGGATGCTCGAACTGCACC2157.14484504F-2242.74Japan
GW.4ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-1981.59Japan
GW.4ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-2648.21Japan
GW.4SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1403.3Japan
GW.4SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-2512.5Japan
GW.4SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-2871.9Japan
GS.4ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
GS.4ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
GS.4ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-18581.4France
GS.4ORF1abCN-CDC-ORF1abCCCTGTGGGTTTTACACTTAA2142.861334213362F-20516.2China
GS.4ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-20695.4Singapore
GS.4ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
GS.4ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
GS.4ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
GS.4ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
GS.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GS.4SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-27219.1China
GS.4SWon-SCTACATGCACCAGCAACTGT20502311423133F-17500.9South Korea
GS.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GS.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GS.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GS.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GS.4NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
GS.4NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
GS.4NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
GS.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GS.4NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
GS.4NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
GS.4NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
GS.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GS.4NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
GS.4NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
GS.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GS.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GS.4ORF1abNIID WH-1 F501R913TTCGGATGCTCGAACTGCACC2157.14484504F-2242.74Japan
GS.4ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-1981.59Japan
GS.4ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-2648.21Japan
GS.4SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used